Drugs that contain Estrogens, Conjugated Synthetic B
1. Enjuvia patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6855703 | ASPEN | Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds |
Feb, 2021
(3 years ago) | |
| US6660726 | ASPEN | Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same |
Mar, 2021
(3 years ago) | |
Market Authorisation Date: 20 December, 2004
Treatment: Treatment of moderate to severe vasomotor symptoms associated with menopause; Treatment of moderate to severe vaginal dryness and pain with intercourse, symptoms of vulvar and vaginal atrophy, associa...
Dosage: TABLET;ORAL
More Information on Dosage
ENJUVIA family patents
